Abstract:Anti-cancer response of cell lines to drugs is in urgent need for individualized precision medical decision-making in the era of precision medicine. Measurements with wet-experiments is time-consuming and expensive and it is almost impossible for wide ranges of application. The design of computational models that can precisely predict the responses between drugs and cell lines could provide a credible reference for further research. Existing methods of response prediction based on matrix factorization or neural networks have revealed that both linear or nonlinear latent characteristics are applicable and effective for the precise prediction of drug responses. However, the majority of them consider only linear or nonlinear relationships for drug response prediction. Herein, we propose a Dual Branch Deep Neural Matrix Factorization (DBDNMF) method to address the above-mentioned issues. DBDNMF learns the latent representation of drugs and cell lines through flexible inputs and reconstructs the partially observed matrix through a series of hidden neural network layers. Experimental results on the datasets of Cancer Cell Line Encyclopedia (CCLE) and Genomics of Drug Sensitivity in Cancer (GDSC) show that the accuracy of drug prediction exceeds state-of-the-art drug response prediction algorithms, demonstrating its reliability and stability. The hierarchical clustering results show that drugs with similar response levels tend to target similar signaling pathway, and cell lines coming from the same tissue subtype tend to share the same pattern of response, which are consistent with previously published studies. As is known, the phenotype of cancer is closely related to gene expression in the human body. In the era of precision medicine, an increasing amount of anti-cancer drug response data is urgently needed for individualized therapy. Measurements with wet-experiments are time-consuming and costly, and computational methods are necessary. Existing methods mainly focused predominantly on linear or nonlinear relationships between cells and drugs for prediction. However, it has been shown that both linear and nonlinear relationships could contribute to more precise response prediction. Here, we propose a Dual Branch Deep Neural Matrix Factorization (DBDNMF) method to better use both linear and nonlinear relationships and the experimental results show that it outperforms state-of-the-art algorithms. Our results suggest that drugs showing similar response levels tend to target similar signaling pathways while cell lines sharing similar response patterns tend to come from the same tissue subtype. The analysis of experimental results may benefit medical decision-making.

Domain-invariant features for mechanism of action prediction in a multi-cell-line drug screen

Efficient parameterization of large-scale mechanistic models enables drug response prediction for cancer cell lines

Multi-task deep latent spaces for cancer survival and drug sensitivity prediction

Predicting cell morphological responses to perturbations using generative modeling

Predicting Cellular Responses to Novel Drug Perturbations at a Single-Cell Resolution

Model ensembling as a tool to form interpretable multi-omic predictors of cancer pharmacosensitivity

Multi-task deep latent spaces for cancer survival and treatment response prediction

SYSTEMATIC ASSESSMENT OF ANALYTICAL METHODS FOR DRUG SENSITIVITY PREDICTION FROM CANCER CELL LINE DATA

Learning and actioning general principles of cancer cell drug sensitivity

Modular Within and Between Score for Drug Response Prediction in Cancer Cell Lines.

ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning

Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Unleashing high content screening in hit detection - Benchmarking AI workflows including novelty detection

DBDNMF: A Dual Branch Deep Neural Matrix Factorization method for drug response prediction

WMMDCA: Prediction of Drug Responses by Weight-Based Modular Mapping in Cancer Cell Lines

Kinome-Wide Virtual Screening by Multi-Task Deep Learning

An Innovative Multi-Omics Model Integrating Latent Alignment and Attention Mechanism for Drug Response Prediction

The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer

Personalised Medicine: Establishing predictive machine learning models for drug responses in patient derived cell culture

Machine learning prediction of oncology drug targets based on protein and network properties